HPV & STI DETECTION BY NGS
  • This is the first NGS kit which is available worldwide to detect HPV and STI infections simultaneously.
  • It is a single-step amplification and sequencing assay, wherein 41 HPVs and STIs ie i 28 human papillomaviruses (HPV) and 13 other sexually transmitted infections are detected simultaneously on Illumina NGS sequencing platforms.
  • List of HPVs and other STIs targeted by this kit
    • a. High-risk HPV: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, 73, 26, 53, 82
    • b. Low-risk HPV: 6, 11, 40, 42, 43, 44, 55, 61, 81, 83
    • c. Other STIS
    • Chlamydia trachomatis (CT)
    • Neisseria gonorrhoeae (NG)
    • Mycoplasma genitalium (MG)
    • Trichomonas vaginalis (TV)
    • Treponema pallidum (TP)
    • Haemophilus ducreyi (HD)
    • Mycoplasma hominis (MH)
    • Ureaplasma urealyticum (UU)
    • Ureaplasma parvum (UP)
    • Lymphogranuloma venereum (LGV1 & 2)
    • Herpes simplex virus type 1 (HSV1)
    • Herpes simplex virus type 2 (HSV2)
    • Varicella zoster virus (VZV)
    • Sensitivity and Specificity has been 100% for 50 copies of 43 targets
    • Ability to sequence many targets simultaneously
    • Higher sequencing depth enables higher sensitivity (down to 1%)
    • Higher sample throughput with sample multiplexing
    • Faster turnaround time for high sample volumes